News | June 02, 2009

Telehealth Products Help Cut Costs, Reduce Hospitalizations for Congestive Heart Failure

June 2, 2009 - IDEAL LIFE Inc. and home care agency Bayada Nurses Inc. said today hospitalizations for patients using IDEAL LIFE’s remote health management products for congestive heart failure (CHF) and hypertension decreased 40 to 60 percent since the program began in September 2007.

The clinical results were so favorable that Bayada Nurses, one of the nation’s largest home health providers, expanded use of the IDEAL LIFE system across offices in Pennsylvania, Arizona and New Jersey.

Participating patients monitored their daily weight fluctuations - a key indicator of heart failure - and blood pressure using both a Bluetooth-enabled digital weight scale (the IDEAL LIFE Body Manager) and a blood pressure monitor (the IDEAL LIFE BP-Manager). The wireless telemedicine devices easily and automatically store and send health information to designated medical professionals, enabling them to make timely decisions that can prevent unnecessary hospital stays. Bayada staff also found IDEAL LIFE’s products provided opportunities for “teachable moments” with their patients, especially when symptoms were most acute.

“Preventing just one hospitalization can save health plans as much as $30,000,” said Brian Farber, director of the telehealth program at Bayada Nurses. “Using IDEAL LIFE’s affordable and effective products, we now have the potential to help millions of people better manage their health and reduce healthcare costs.”

IDEAL LIFE is one of the most widely-used systems for remote health monitoring in North America, with FDA-approved products designed for individuals with chronic conditions such as CHF, diabetes, obesity, and hypertension. The company’s consumer-inspired monitoring devices can be used with cell phones, land-line phones, and the Internet, and have gained enthusiastic support from medical experts across the country.

For more information:

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Hospital Readmissions Analysis Across All Ages, Insurance Types Identifies High-Risk Groups
News | Business| July 20, 2017
July 20, 2017 — Clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) recently published a first-of-i
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
Overlay Init